| Literature DB >> 35018272 |
Asim Munir Alvi1, Ahmed Imran Siddiqi2, Umal Azmat2, Waqas Shafiq2, Sardar A Khan3.
Abstract
Primary amenorrhea is a serious medical condition. A thorough clinical assessment is necessary for a timely and correct diagnosis and management of this ailment to prevent long-term health and social problems. Turner's syndrome is considered one of the important causes of primary amenorrhea, with an incidence of one in 2,500 to one in 3,000 live-born girls. In this report, we present an interesting case involving multinodular goiter, hypothyroidism, and primary amenorrhea. A 24-year-old woman with a history of multinodular goiter and hypothyroidism attended an endocrine clinic with fine-needle aspiration cytology (FNAC) report of her bilateral thyroid nodules, which showed Bethesda category IV. She had a history of learning difficulties. During detailed history-taking, the patient also complained of primary amenorrhea. Clinical examination showed a lack of secondary sexual characters. Biochemical, imaging, and cytogenetic investigations were suggestive of absent ovaries and fallopian tubes, streaked uterus, hypergonadotropic hypogonadism, and X0 karyotyping. The learning objectives of this case report are as follows: firstly, in countries with a lack of awareness and limited health resources, patients may present with one of the manifestations of Turner's syndrome. Clinicians from all specialties should be aware of the clinical features of this relatively rare entity and should try to make the most of incidental clinical findings. Secondly, clinicians should be more vigilant and thorough in their clinical assessment of patients with learning difficulties to minimize the chances of missing a clinical diagnosis.Entities:
Keywords: hypergonadotropic hypogonadism; hypothyroidism; multinodular goiter; primary amenorrhea; turner syndrome
Year: 2021 PMID: 35018272 PMCID: PMC8742137 DOI: 10.7759/cureus.20285
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Hormonal profile, imaging, and karyotyping
| Test name | Value | Reference range |
| Luteinizing hormone (LH) | 17.6 mIU/mL | 1.1–14.7 |
| Follicle-stimulating hormone (FSH) | 130 mIU/mL | 2.8–11.3 |
| Estradiol | 28.67 pg/mL | 19.5–214 |
| Dehydroepiandrosterone sulfate (DHEA-SO4) | 68.9 ug/dL | 35–430 |
| Prolactin | 11.4 ng/mL | 1.90–25 |
| Testosterone | 14.28 ng/dL | 12–59.4 |
| Cortisol | 17.52 mcg/dL | 5.27–22.45 |
| Thyroid-stimulating hormone (TSH) | 5.35 uIU/mL | 0.35–5.5 |
| Free T4 | 1.01 ng/dL | 0.89–1.76 |
| Ultrasound pelvis | Absent cervix, uterus, and bilateral ovaries | |
| Magnetic resonance imaging (MRI) pelvis | Extremely rudimentary uterus with streak-like configuration. No ovarian tissue was identified | |
| Echocardiography | Unremarkable study | |
| Ultrasound thyroid | Multinodular goiter | |
| Karyotyping | X0 |
Figure 1Ultrasound pelvis (arrow showing rudimentary uterus)
Figure 2MRI abdomen and pelvis (arrow showing rudimentary uterus)
MRI: magnetic resonance imaging
Figure 3Karyotyping (showing X0 karyotype)
Causes of primary amenorrhea
CAH: congenital adrenal hyperplasia; IBD: inflammatory bowel disease; PCOS: polycystic ovarian syndrome; SOD: septo-optic dysplasia; PWS: Prader-Willi syndrome; LMMBS: Laurence-Moon-Bardet-Biedl syndrome; AIS: androgen insensitivity syndrome; OCPs: oral contraceptive pills; SSRIs: selective serotonin reuptake inhibitors
| Hypogonadotropic hypogonadism | Hypergonadotropic hypogonadism | Normogonadotropic hypogonadism |
| Constitutional delay/self-limited delayed puberty | Premature ovarian insufficiency/failure (Turner's syndrome, gonadal dysgenesis, autoimmune oophoritis, polyglandular autoimmune syndrome, radiation therapy, surgery, chemotherapy, infections) | Pituitary (hyperprolactinemia) |
| Congenital hypogonadotropic hypogonadism (Kallmann syndrome) | Adrenals (non-classic CAH, androgen-secreting tumors, Addison's disease) | |
| Functional hypothalamic problems (anorexia nervosa, chronic diseases like celiac disease, IBD, strenuous exercise, stress, psychiatric issues) | Ovaries (PCOS, androgen- or estrogen-secreting tumors) | |
| Syndromic congenital hypogonadotropic hypogonadism (CHARGE syndrome, CAH, SOD, PWS, LMBBS) | Uterus (Müllerian structures agenesis, cervical agenesis, AIS, pregnancy) | |
| Pituitary hormone deficiencies due to its destruction (benign adenomas and other tumors; cysts, infiltrative disorders, previous surgery, head trauma, pituitary apoplexy, vascular lesions, empty sella syndrome, radiation therapy) | Vagina (atresia, transverse septum, distal atresia) | |
| Thyroid problems (hypothyroidism or hyperthyroidism) | Imperforation of hymen | |
| Medications (anesthetics, anticonvulsants, antipsychotics, opiates, anti-emetics, SSRIs, OCPs, alcohol abuse, heroin, cocaine, steroids, androgens use) |
Clinical features of Turner's syndrome
GERD: gastroesophageal reflux disease; IBD: inflammatory bowel disease
| Systems/problems | Features that can be present in Turner’s syndrome |
| General | Short stature, mostly normal intelligence, female phenotype |
| Cardiovascular | 17-45% have congenital heart diseases; aortic coarctation and bicuspid aortic valve are most common; others include left-sided cardiac defects, hypertension, mitral valve prolapsed, and conduction defects |
| Endocrine | Hypothyroidism; gonadal dysgenesis is a cardinal feature of Turner's syndrome; infertility, diabetes mellitus |
| Eye, ENT problems | Strabismus, ptosis, cataract, nystagmus, color blindness, recurrent otitis media, sensorineural hearing loss |
| Gastrointestinal problems | GERD, IBD, celiac disease, gall bladder disease |
| Renal problems | Structural renal problems (horseshoe-shaped kidney, duplication of collecting system) |
| Musculoskeletal problems | Dislocation of patellar bone and pain in the knee joint; deformity of the ulnar head causes the increase-carrying angle of the arm and may result in a decreased range of motion, Madelung's deformity, and congenital dislocation of the hip, high arched palate, spinal deformities, and osteoporosis |
| Dermatological problems | Congenital puffiness of hands and feet, increased melanocytic nevi, increased risk of keloid formation, premature fine wrinkling of facial skin |
| Neoplasm | Colon cancer, gonadoblastoma, dysgerminoma, risk of endometrial carcinoma in patients with a history of unopposed estrogen treatment |